COVID-19SARS-CoV-2Type 1 diabetesDiabetic ketoacidosisCoronavirus disease 2019 (COVID-19) has aroused global health concerns, particularly in relation to diabetes where it has been associated with poorer outcomes. The bulk of the evolving evidence in diabetes and COVID-19 relates to type 2 ...
also adversely impact persons with diabetes by limiting their access to clinical care, healthy diet, and opportunities to exercise. Most antidiabetic medications can continue to be used in patients with mild COVID19 but switching over to insulin is preferred in severe disease. Introduction Coronavirus...
The new database is called theCOVIDIABregistry and has been specifically designed to helpmedical researchersbetter understand the link between COVID-19 and diabetes. The data was collected frompatientsregarding their circumstances, including whether they were new-onset. The developers suggest the amount...
F. JAK out of the box; the rationale behind Janus kinase inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations. Cardiovasc. Endocrinol. Metab. 10, 80–88 (2021). Henderson, L. A. et al. American College of Rheumatology clinical guidance for multisystem ...
The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: a nationwide cohort from the US using the Cerner Real-World Data. PLoS One. 2022;17(4):e0266809. doi:10.1371/journal.pone.0266809 PubMedGoogle ScholarCrossref 30. Birabaharan M...
Non-steroidal anti-inflammatory drugs (NSAIDs) showed promising clinical efficacy toward COVID-19 (Coronavirus disease 2019) patients as potent painkillers and anti-inflammatory agents. However, the prospective anti-COVID-19 mechanisms of NSAIDs are not
Therefore, in the present study, we explored the expression and associated biological processes of ACE2 and other SARS-CoV-2 entry factors in kidney cells from healthy living donors (LDs), patients with diabetic kidney disease (DKD), and COVID-19 patients that required hospitalization (COV). ...
Several observational studies demonstrated that pregnant individuals with COVID-19 had a higher risk of preeclampsia and preterm birth. We aimed to determine whether women with COVID-19 diagnosis had adverse pregnancy outcomes. A two-sample Mendelian ran
(Wysocki et al., [66]) - Animal Model - ACE2 expression is increased at the posttranscriptional level in renal cortex of the db/db STZ-induced diabetic mice. (Roca-Ho, Riera, Palau, Pascual, - Animal Model & Soler, [67]) - Diabetes up-regulates ACE2 mainly in serum, liver, and ...
According to recent researches, people with diabetes mellitus (type 1 and 2) have a higher incidence of coronavirus disease 2019 (COVID-19), which is caused by a SARS-CoV-2 infection. In this regard, COVID-19 may make diabetic patients more sensitive to hyperglycemia by modifying the immuno...